Brandywine Global Investment Management’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $12.5M | Sell |
139,151
-993
| -0.7% | -$94.2K | 0.08% | 213 |
|
|
2025
Q3 | $13.8M | Buy |
140,144
+9,803
| +8% | +$971K | 0.09% | 201 |
|
|
2025
Q2 | $11.9M | Buy |
130,341
+9,786
| +8% | +$946K | 0.08% | 230 |
|
|
2025
Q1 | $13.6M | Buy |
+120,555
| New | +$12.9M | 0.1% | 203 |
|
|
2024
Q4 | – | Sell |
-134,101
| Closed | -$14.1M | – | 728 |
|
|
2024
Q3 | $14.1M | Buy |
+134,101
| New | +$14.6M | 0.09% | 203 |
|
|
2023
Q1 | – | Sell |
-24,010
| Closed | -$3.06M | – | 775 |
|
|
2022
Q4 | $3.06M | Sell |
24,010
-359,162
| -94% | -$41.7M | 0.02% | 484 |
|
|
2022
Q3 | $40.1M | Sell |
383,172
-5,330
| -1% | -$585K | 0.37% | 79 |
|
|
2022
Q2 | $40.8M | Sell |
388,502
-7,820
| -2% | -$928K | 0.36% | 87 |
|
|
2022
Q1 | $50.7M | Sell |
396,322
-12,498
| -3% | -$1.51M | 0.37% | 79 |
|
|
2021
Q4 | $50.4M | Buy |
408,820
+234,922
| +135% | +$30.7M | 0.36% | 78 |
|
|
2021
Q3 | $24.7M | Buy |
173,898
+19,844
| +13% | +$2.92M | 0.19% | 137 |
|
|
2021
Q2 | $24.1M | Sell |
154,054
-1,429
| -0.9% | -$231K | 0.18% | 145 |
|
|
2021
Q1 | $24.2M | Sell |
155,483
-3,100
| -2% | -$480K | 0.18% | 145 |
|
|
2020
Q4 | $23.7M | Sell |
158,583
-3,622
| -2% | -$512K | 0.2% | 136 |
|
|
2020
Q3 | $21.4M | Sell |
162,205
-2,942
| -2% | -$384K | 0.21% | 122 |
|
|
2020
Q2 | $19.1M | Sell |
165,147
-1,525
| -0.9% | -$176K | 0.2% | 123 |
|
|
2020
Q1 | $16.4M | Sell |
166,672
-192,107
| -54% | -$25.2M | 0.2% | 119 |
|
|
2019
Q4 | $52M | Sell |
358,779
-53,974
| -13% | -$7.45M | 0.37% | 69 |
|
|
2019
Q3 | $55M | Sell |
412,753
-25,364
| -6% | -$3.28M | 0.4% | 60 |
|
|
2019
Q2 | $50.1M | Buy |
438,117
+219,388
| +100% | +$25.7M | 0.35% | 68 |
|
|
2019
Q1 | $27.1M | Sell |
218,729
-3,477
| -2% | -$395K | 0.19% | 108 |
|
|
2018
Q4 | $22.4M | Sell |
222,206
-37,811
| -15% | -$4.25M | 0.17% | 128 |
|
|
2018
Q3 | $33.2M | Sell |
260,017
-4,063
| -2% | -$483K | 0.21% | 110 |
|
|
2018
Q2 | $28.6M | Sell |
264,080
-1,224
| -0.5% | -$133K | 0.18% | 121 |
|
|
2018
Q1 | $28.1M | Sell |
265,304
-96,973
| -27% | -$11.3M | 0.18% | 121 |
|
|
2017
Q4 | $42.4M | Buy |
+362,277
| New | +$41M | 0.25% | 94 |
|
|
2015
Q2 | – | Sell |
-249,960
| Closed | -$28.5M | – | 1034 |
|
|
2015
Q1 | $28.5M | Buy |
249,960
+5,613
| +2% | +$640K | 0.18% | 112 |
|
|
2014
Q4 | $26.9M | Buy |
244,347
+20,387
| +9% | +$2.15M | 0.18% | 115 |
|
|
2014
Q3 | $21.9M | Buy |
223,960
+39,521
| +21% | +$3.89M | 0.16% | 118 |
|
|
2014
Q2 | $18.6M | Buy |
184,439
+24,844
| +16% | +$2.42M | 0.15% | 121 |
|
|
2014
Q1 | $14.7M | Buy |
159,595
+854
| +0.5% | +$78.7K | 0.13% | 139 |
|
|
2013
Q4 | $14.4M | Buy |
158,741
+267
| +0.2% | +$23.1K | 0.13% | 131 |
|
|
2013
Q3 | $12.6M | Buy |
158,474
+193
| +0.1% | +$15.2K | 0.13% | 142 |
|
|
2013
Q2 | $11.5M | Buy |
+158,281
| New | +$11.8M | 0.12% | 146 |
|
Other funds holding ZBH
Brandywine Global Investment Management's ZBH Position: Q4 2025 in Review
Brandywine Global Investment Management reduced its Zimmer Biomet (ZBH) stake by 0.71% in Q4 2025, selling an estimated $94.2K and leaving 139,151 shares worth $12.5M. The position accounts for 0.08% of the portfolio, ranked #213.
Brandywine Global Investment Management first reported a position in ZBH in Q2 2013 and has held it in 34 quarters since. The position peaked at $55M in Q3 2019. 945 funds tracked by Wall St. Rank hold ZBH as of Q4 2025.
- Brandywine Global Investment Management held 139,151 shares of Zimmer Biomet worth $12.5M as of Q4 2025.
- Brandywine Global Investment Management sold 993 Zimmer Biomet shares in Q4 2025, an estimated $94.2K.
- Zimmer Biomet made up 0.08% of Brandywine Global Investment Management's portfolio in Q4 2025, its #213 holding.
- Brandywine Global Investment Management first reported a position in Zimmer Biomet in Q2 2013 and has held it in 34 quarters since.
- Brandywine Global Investment Management's Zimmer Biomet position peaked at $55M in Q3 2019.
- 945 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2025.
Based on Brandywine Global Investment Management's 13F filing for Q4 2025, filed 11 Feb 2026.